MedPath

Comparative study of Letrozole vsGanirelix acetate in ovarianhyperstimulation syndrome (OHSS)

Phase 4
Conditions
Health Condition 1: N00-N99- Diseases of the genitourinary system
Registration Number
CTRI/2020/10/028674
Lead Sponsor
Ankoor Fertility Clinic
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
105
Inclusion Criteria

Body mass index is 18 to 29

USG pelvis normal with presence of both ovaries

AFC > 20 (More than 20 follicles developing on folliculometry)

AMH > 5

Basal levels of oestradiol (<= 50 pg/ml) on day 1 of stimulation

Serum estradiol level > 4000 pg/ml on the day of trigger

All patients had to sign an informed consent and Review Board permission was obtained

Number of oocyte retrieval >25;

Estradiol level > 3500 pg/mL on the day of trigger

Clinical or ultrasonography proven OHSS on the day of oocyte retrieval, such as

ultrasonographic evidence of ascites.

Ovary diameter 10cm on one or both sides on day 3 after oocyte retrieval

Puncture follicle number should be 30 (follicular diameter14mm on oocyte retrieval day)

Exclusion Criteria

1.All women with serum estradiol levels < 2500 on day of trigger

2.Not receiving dual trigger

3.Contraindications to study drugs

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath